Not applicableEnded earlyNCT01648959What this trial is testingIntra Cranial EEG Activity During Dexmedetomidine SedationWho this might be right forComplex Partial Seizures University Health Network, Toronto 5
Large-scale testing (Phase 3)Study completedNCT00740623What this trial is testingThe Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.Who this might be right forEpilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more SK Life Science, Inc. 547
Large-scale testing (Phase 3)Study completedNCT00744731What this trial is testingAn Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset SeizuresWho this might be right forEpilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more SK Life Science, Inc. 403
Not applicableEnded earlyNCT00013845What this trial is testingEvaluation and Treatment of Patients With EpilepsyWho this might be right forEpilepsy National Institute of Neurological Disorders and Stroke (NINDS) 1,278
Not applicableLooking for participantsNCT07012148What this trial is testingOptimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and WearablesWho this might be right forFocal EpilepsyGeneralized SeizureDrug Refractory Epilepsy Mayo Clinic 12
Large-scale testing (Phase 3)Study completedNCT00235755What this trial is testingRetigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in EpilepsyWho this might be right forSeizures GlaxoSmithKline 539
Large-scale testing (Phase 3)Study completedNCT00866775What this trial is testingSafety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic DrugsWho this might be right forEpilepsy With Simple or Complex Partial Onset Seizures Sumitomo Pharma America, Inc. 193
Large-scale testing (Phase 3)Study completedNCT00310375What this trial is testingOpen-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind TrialWho this might be right forEpilepsy GlaxoSmithKline 181
Post-approval studies (Phase 4)Ended earlyNCT01266291What this trial is testingSabril for Complex Partial Seizures in Adult Tolerability Study (TS) PatientsWho this might be right forComplex Partial Seizures University of Pennsylvania 1
Testing effectiveness (Phase 2)Study completedNCT02150213What this trial is testingMedical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492Who this might be right forAdrenocortical AdenomaEndometrial Stromal Sarcomas Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)Study completedNCT01002820What this trial is testingA Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601Who this might be right forEpilepsy, Complex Partial Marinus Pharmaceuticals 11
Large-scale testing (Phase 3)Study completedNCT01963208What this trial is testingPhase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label ExtensionWho this might be right forDrug Resistant Partial Onset Seizure Marinus Pharmaceuticals 405
Large-scale testing (Phase 3)Study completedNCT00537238What this trial is testingPregabalin Versus Levetiracetam In Partial SeizuresWho this might be right forPartial Seizures Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 509
Large-scale testing (Phase 3)Study completedNCT00433667What this trial is testingThe Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.Who this might be right forEpilepsyEpilepsy, FocalSeizure Disorder+2 more SK Life Science, Inc. 563
Not applicableStudy completedNCT00044252What this trial is testingRole of Hormones in Susceptibility to Seizures in Women With EpilepsyWho this might be right forEpilepsy National Institute of Neurological Disorders and Stroke (NINDS) 50
Large-scale testing (Phase 3)Study completedNCT00143143What this trial is testingPregabalin Open-Label Extension Trial in Patients With Partial SeizuresWho this might be right forEpilepsies, PartialEpilepsy, Complex Partial Pfizer 300
Large-scale testing (Phase 3)Ended earlyNCT02519439What this trial is testingA Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset SeizuresWho this might be right forDrug Resistant Partial Onset Seizure Marinus Pharmaceuticals 26
Large-scale testing (Phase 3)Study completedNCT01713946What this trial is testingA Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset SeizuresWho this might be right forTuberous Sclerosis Complex-associated Refractory Seizures Novartis Pharmaceuticals 366
Not applicableStudy completedNCT03443388What this trial is testingNovel Helmet Design in Patients With SeizuresWho this might be right forDrug Resistant EpilepsyDrop SeizuresGeneralized Tonic Clonic Seizure+2 more Michael A. Gelfand, MD, PhD 9
Large-scale testing (Phase 3)Study completedNCT01749046What this trial is testingRemegal Fixed Dose as Adjunctive Therapy in Patients With Partial SeizuresWho this might be right forEpilepsySimple Partial SeizuresComplex Partial Seizures+1 more Valexfarm 224